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As part of an antifungal discovery program, the crude 
extract of a Streptomyces sp. from Ecuador, MF-EA-705, 
was found to display broad-spectrum antifungal activity 
against Candida spp. and Aspergillus spp. T he extract was 
found to contain the known weakly-antibacterial compound 
actinopyrone A (1 ), 1l previously isolated from Streptomyces 
pactum. We report herein the production, isolation, 
structure elucidation and biological activities of two new 
compounds MF-EA-705a (2) and MF-EA-705/3 (3). A 
structurally similar compound has been reported in the 
microbial naturdl product literature, NFAT-133 (4),2> known 
to be an immunosuppressive agent in vitro. 
An 8-cm sporulation agar plate was inoculated with a 
100 pi portion of frozen MF-EA-705 stock, and incubated 
at 28°C until growth (medium, beige-white) was observed 
( 16 days). Sterile phosphate-buffered saline (6 mJ) was then 
added. The MF-EA-705 mycelia and spores were gently 
scraped with a sterile loop, and a 3-ml portion of the 
resultant suspension was pipetted into a 500-ml flask 
containing sterile ATCC- 172 media (150 mi. 2% soluble 
starch, 1% dextrose, 0.5% NZ amine type A, 0.3% Difco 
beef extract, 0.5% Difco bacto peptone, 0.5% yeast extract, 
0.1% CaC03, presterile pH 7.0). The seed culture was 
incubated for 24 hours at 28°C, 200 rpm, and 85% 
humidity. Each of five production flasks (2800-ml 
Fcmbach) containing 500 ml of production media (5% 
glycerol, 2.5% corn meal, 0.5% llyeast 444, presterile pH 
7.0) was inoculated with 20 ml of seed culture prepared 
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above and incubated at 28°C, 160 rpm, and 85% humidity 
for 192 hours (8 days). The fermentation was harvested by 
centrifugation ( 4,500 rpm, 15 minutes, 4°C) and the 
supernatant (2200 ml) was decanted and stored at 4°C until 
used. The pellet was extracted with I 000 ml of 90% 
aqueous acetone for 2 hours and the extr~ct was separated 
from the cell debris by centrifugation ( 4,500 rpm, 15 
minutes, 4°C) and concentrated in vacuo (30 mbar, 30°C). 
The remaining aqueous suspension (200 ml) was also stored 
at 4°C until used. 
The production of the bioactive components and their 
purification was monitored by inhibitory activity against 
Candida albicans in a cut-well agar diffusion assay. The 
fcnnentation supernatant and the concentrated pellet extract 
were recombined and adsorbed onto a column (2.5 em i.d.X 
22 em L, 110 ml) packed with D iaion® HP20 (Mitsubishi 
Kasei) that had been equilibrated in water (1 000 ml). The 
column was sequentially eluted at 5 ml/minute with water 
(600 ml), a gradient of 0 to 20% acetone (350 ml), 20% 
acetone (350 ml), a gradient of 20 to 100% acetone (550 
ml) and I 00% acetone (550 ml), collecting fractions at 
5-minute intervals. The active eluates (60- 80% acetone) 
were combined and concentrated in vacuo (<30°C), and 
the residual aqueous solution was lyophi lized to yield 1.8 g 
of crude material. The sample was dissolved in a mixture of 
1.25 ml of buffer A (0. 1 M NH40Ac, pH 4.9) and 3.75 ml of 
methanol, and was top-loaded on a column (2.2 cmX35 em, 
] 35 ml) packed with cl8 silica gel (Amicon) that had been 
pre-equilibrated with 75% methanol in 0.1 M NH40Ac (pH 
4.9). The column was eluted at 5 ml/minute with the same 
solvent mixture. The active fractions were each analyzed by 
HPLC (Amicon C 18, 4.6mmX100mm, l.7ml; 75% 
methanol in 0.1 M NH40Ac, pH 4.9) and the fractions 
corresponding to separate peaks (as detected by UV) 
combined accordingly. These pooled active fractions were 
further purified by reverse-phase HPLC on a Matrex C 18 
column (MODcoJ®, 2.12cmX25cm, 90ml) eluted with 
75% methanol in 0.1 M NH40Ac pH 4.9, to obtain MF-EA­
705a (2, 65 mg), MF-EA-705j3 (3, 20 mg) and actina­
pyrone A (1, 12 mg). The physico-chemical properties of 
compounds 2 and 3 are summarized in Table 1. 
MF-EA-705a (2) was isolated as an optically-inactive 
colorless oil. The molecular formula <;0H2p 2, which 
requires ten degrees of w1saturation, was established by 
HRFABMS [mlz 295.1688 (M+HtJ and by interpretation 
of the 1H and 13C NMR data. The IR spectrum contained 
.typical carboxylic acid bands at 3420 and 1710 em - I, and 
the UV absorption at 280 nm was consistent with a 
chromophore arising due to conjugation. The aliphatic 
region of the 1H NMR spectrum (Table 2) contained two 
methyl singlets at 8 2.34 (Me-19) and 2.02 (Me-20) and a 
single methylene signal at 8 3.05 (H-2). Two one-proton 
coupled signals at 5.10 and 5.27 (H-18a and H-18b) were 
correlated (HMQC) to a single carbon at 8 117 .2, 
confirming the presence of a terminal methylene group. 
From 1H NMR, DEPT and HMQC experiments, the 
presence of eleven additional methine carbons and five sp2 
quaternary carbons, one of which was an acid carbonyl 
(8 17'7.0), was strongly inferred. ln addition to the data 
presented above, the COSY experiment allowed the 
Table 1. Physico-chemical properties ofMF-EA-705 a and j3. 
MF-EA-705a MF-EA-705p 
Appearance 
Molecular Formula 
HRFABMS 
Calc. 
Found 
UV Arnax (MeOH) nm, £ 
IR Vrnu (neat) cm·1 
Solubility 
clear oil 
(M+Ht 
295. 1698 
295. I 688 
3420, 1710 
MeOH, CHCI3, ethyl acetate 
clear oil 
[M+Ht 
297.1855 
297.1856 
240 (35630) 
280 (51330) 
3390, 1710 
MeOH, CHCI3, ethyl acetate 
Table 2. 1H NMR (400 MHz, 25°C, CDCI3) and 13C NMR (100 MHz) data ofMF-EA-705a (2). 
Cno. Oc OH mull, J (Hz) HMBC 
I 177.0 
2 37.7 3.05 d,2H, 7.1 177.0, 123.4, 134.6 
3 123.4 5.64 dt, IH, 15, 7.3 177.0, 37.7, 130.3 
4 134.6 5.97 dd, IH, 15, II 37.7, 130.6 
5 130.3 6.09 dd. I H, 15.6, 11.3 123.4, 134.6, 128.3 
6 130.6 5.77 dd, IH, 14.8, II 134.6 
7 128.3 6.15 d, IH, I 1.2 130.6, 138.1, 26.2 
8 139.5 
9 138.1 
LO 128.9 6.91 d, 1H, 7.7 139.5, 134.2, 136.7 
II 128.4 7.02 dd, IH, 7 .7, 1.1 138.1, 125.5, 21.2 
12 136.7 
13 125.5 7.40 br s, 1H 138.1, 128.4, 130.8, 21.2 
14 134.2 
IS 130.8 6.50 d, IH, 15.7 125.5, 130.1 , 137.6 
16 130.1 6.71 dd. IH, 15.7, 10.4 134.2, 130.8, 137.6 
17 137.6 6.42 dt, IH, 16.8, 10 
18a I 17.2 5.10 dd, 1H, 10.1, 0.8 130. 1 
18b 5.27 dd, 1H. 16.8, 0.8 130.1, 137.6 
19 21.2 2.34 s, 3H 125.5, 136.7, 128.4 
20 26.2 2 .02 s, 3H 128.3, 139.5, 138.1 
1-0H 5.60 br s, lH 
construction of several partial structures that could then be 
interconnected using data obtained from the HMBC 
experiment. The 1 ,2,4-trisubstituted benzene moiety was 
assigned on the basis of the coupling constants of the H-1 0, 
H-11 and H-13 signals and COSY correlations between H­
10 and H-11. Key long-range HMBC correlations (Figure 
2a) are as follows: H-13 to C-9, C-1 J, C-15 and C-19; H-11 
to C-9 and H-10 to C-8, C-14 and C-12. These results are 
consistent with a trisubstituted aromatic dng. 
The remainder of the molecule was established as 
follows. The 1H NMR signals at 8 5.64 (H-3), 5.97 (H-4), 
6.09 (H-5), 5.77 (H-6) and 6.15 (H-7), each integrating to 
one proton, were assigned on the basis of COSY to the 
hydrogens on a set of three conjugated olefins. The 
geometries of the C3- C4 and C5-C6 olefins were assigned 
as trans on the basis of the 1H coupling constants (Table 2) 
and the NOESY data (Figure 2b). The configuration of the 
C7-C8 olefin was assigned as shown based on a NOESY 
correlation between H-7 and H-20. The placement of the C­
20 methyl group at C-8 was assigned on the basis ofCOSY 
and HMBC data. Further HMBC correlations from H-3 to 
C-1 and C-5, and from H-2 to C-4 established the terminal 
carboxylic acid portion of the chain. The remaining portion 
of the molecule, C-15 to C-18, was determined similarly. 
Fig. 2. (a) Selected HMBC and (b) NOESY 
correlations for EA-705a (2). 
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Table 3. 11-l NMR (400 MHz, 25°C, CDCI3) and 13C NMR (100MHz) data ofMF-EA-705a (3). 
·---- ------- -- -
Cno. oc OH 
I 177.2 
2 37.7 3.06 
3 123.0 5.65 
4 134.8 5.99 
5 129.8 6.09 
6 131.0 5.81 
7 127.6 6.09 
8 140.4 
9 138.3 
10 128.5 6.94 
11 127.4 7.02 
12 136.0 
13 130.0 7.06 
14 135.4 
15 127.3 6.20 
16 134.4 5.56 
17 21.8 2.19 
18 14.4 0.97 
19 21.2 2.33 
20 25.6 1.9& 
1-0H. 
* not observed 
The C-19 methyl group was placed at C- 12 on the basis of 
HMBC correlations between CH3- 19 to C-11 and C-13. 
MF-EA-705{3 (3) was isolated as an optically-inactive 
colorless oil. Its molecular formula, C20H240 2, was 2 amu 
heavier than that of MF-EA-705a (2). Analysis of the 
NMR data (Table 3) revealed that the only structural 
changes were saturation of the C-1 7 to C- 18 double bond of 
2, and a cis geometry of the C 15- C 16 double bond. The 
signals at De 137.6 and I 17.2 and Ou 6.42, 5. 1 0 and 5.27 in 
the NMR spectra of 2 were replaced by a methylene carbon 
signal at 21.8 and an additional methyl signal at Oc 14.4 
and oH 0.97 (t, 3H, J 7.5, 7.5 Hz). The new CH3 signal 
showed HMBC correlations to C-16, and H-17 correlated 
to C-15. Further HMBC correlations indicated the chain 
was still attached to C-14 of the benzene ring, although the 
effect of the change was noted in the chemical shift of H-13 
(o 7.40 to 7.06), H-15 (6.50 to 6.20) and H-16 (6.71 to 
5.56). The remaining spectral data suggested the rest of the 
molecule was identical to 2. 
The purified compounds MF-EA-705a (2) and MF-EA­
705{3 (3) were inactive at a concentration of 128)lg/ml 
against Candida albicans, C. glabrata, C. krusei, 
Cryptococcus neoformans, and Aspe1gillus fumigatus. The 
minimum inhibitory concentration (MIC) of (2) against 
C. albicans was determined to be I mg/ml, suggesting the 
mulf,J (Hz) HMBC 
d. 2H, 7 
dt, IH, 15,7 
dd, IH, 15.2. 11 
m, IH 
dd, IH, 15, II 
m, IH 
177.2, 123.0, 134.8 
177.2, 37.7, 129.8 
37.7 
134.8 
138.3, 25.6 
d, IH, 7.4 
br d, IH. 8.2 
140.4, 135.4 
I 38.3, I 30.0, 2 I .2 
br s, IH 138.3, 127.3, 21.2 
d, JH, 11.2 
dl , IH, II , 7 
q, 2H, 7.5 
l, 3H, 7.5 
s, 3H 
s, 3H 
130.0, 21.8 
135.4, 21.8, 14.4 
127.3, 134.4, 14.4 
134.4, 21.8 
130.0, 136.0 
127.6, 140.4, 138.3 
unsuitability of this compound as a drug candidate. The 
activity observed and followed during bioassay-guided 
fractionation was thus due to high concentrations of the 
compound being assayed in the cut-well agar plates. 
Nevertheless, these compounds are interesting novel 
metabolites, with a similar compound having been isolated 
only once previously in the microbial natural product 
literature.21 
Acknowledgements 
We thank UMA VJJAYAM, KAREN LOLANS and KSH!TIJ Moo1 
for biological assays and ANDREW STALEY for helpful 
comments on the manuscript. 
References 
I) 	 YANO, K.; K. YOKOI, J. SATO, J. OONO, T. KOUDA, Y. 
OGAWA & T. NAKASHIMA: Actinopyrones A, B and C, 
new physiologically active substances. J. Antibiotics 39: 
32- 37, 1986 
2) 	 BURRES, N. S.; U. PREMACHANDRAN, S. HOSELTON, 0 . 
CWIK, J. E. HOCHLOWSKI, Q. YE, G. N. SUNGA, J. P. 
KAROWSKI, M. JACKSON, D. N. WHrTIERN & J. B. 
McALPINE: Simple aromatics identified with a NFAT­
IacZ transcnptton assay for the detection of 
immunosuppressants. J. Antibiotics 48: 380- 386, 1995 
